WNT5A and breast carcinoma: Foxy5, a Wnt5a mimicking peptide, has been shown to impair cell motility of breast cancer cell lines with low endogenous Wnt5a levels and to significantly inhibit breast tumor metastasis to lung and liver in vivo [28].